by CyberKnife Miami | Oct 3, 2026 | Improved Imaging Equals a Better Outcome
Madison, Wis. ā Accuray, the manufactuer of CyberKnife Radition Therapy Ā has entered into agreements with Samsung HME America, doing business as NeuroLogica Corp., to pursue advanced volumetric imaging capabilities for the CyberKnife System. The companies announced...
by CyberKnife Miami | Sep 30, 2026 | CyberKnife vs. Surgery for Prostate Cancer
For John, staying active has always been an important part of life. He enjoys being outdoors, working around his rural property. So, when he was diagnosed with prostate cancer, finding a treatment option that aligned with his lifestyle and his evidence-based approach...
by CyberKnife Miami | Sep 3, 2026 | CyberKnife Success Stories, IsoPSA vs PSA
When Kent Lewis was diagnosed withprostate cancer his IsoPSA level was 20. Dr. Mark Pomper, a prostate cancer specialist and board certified radiation oncologist at the CyberKnife Center of Miami says, āAn IsoPSA level is a score from a specialized blood test that...
by CyberKnife Miami | Jul 29, 2026 | CyberKnife for High Risk Prostate Cancer
Data presented at the 2024 Radiosurgery Society Meeting support the use of the CyberKnife System in the treatment of high-risk and recurrent prostate cancer. The studies expand on years of published clinical follow-up with a large number of prostate cancer patients...
by CyberKnife Miami | Jul 25, 2026 | Brain Tumor Treatment Miami
Among the many disorders that impact brain health, brain tumors remain one of the most complex conditions requiring timely diagnosis and specialized treatment. Fortunately, advancements in medical technology such as CyberKnife have transformed the way these tumors are...